Society for Cardiovascular Angiography & Interventions SHOCK 2024

20 $

+ Include:  videos + pptx, size:  GB

+ Target Audience: Interventional Cardiologists, Intensivists, Cardiothoracic Surgeons, and Advanced Practice Providers (APPs) in critical care

Description

+ Include:  videos + pptx, size:  GB

+ Target Audience: Interventional Cardiologists, Intensivists, Cardiothoracic Surgeons, and Advanced Practice Providers (APPs) in critical care

+ Sample video: contact me for sample video

+ Information:

The 2024 SCAI SHOCK: Home of the Shock Team, scheduled for October 17–19, 2024, in Washington, D.C., is a comprehensive, multidisciplinary conference focused on the contemporary management of cardiogenic shock. This step-by-step guide is designed to help institutions build and optimize their cardiogenic shock programs. Led by seasoned leaders, the meeting explores the individual building blocks of shock management, from early recognition by EMS and ED teams to advanced cath lab complexities, team coordination, and post-danger ICU care.

Learning Objectives

The meeting will equip attendees with a comprehensive understanding of shock management, enabling them to:

  • Integrate scientific updates and the latest evidence-based best practices for treating cardiogenic shock and cardiac arrest into clinical care.

  • Implement optimal shock management strategies by utilizing EMS, transportation, and ED for early recognition and nuanced patient care.

  • Apply Shock ICU essentials, including hemodynamic monitoring, vasoactive medications, and determining the appropriate ICU setting (dedicated vs. mixed).

  • Optimize antiplatelet therapy and pharmacodynamic strategies for high-risk shock patients.

  • Navigate complexities in the cath lab, such as understanding right heart hemodynamics, identifying unseen threats, and executing effective communication.

  • Optimize team setup, tracking quality improvement (QI) metrics, and bridging communication gaps between shock clinicians and hospital administrators (C-suite).

  • Execute problem-solving in the Cardiac ICU, including interpreting cardiac indices, troubleshooting MCS devices, and formulating weaning strategies.

  • Manage post-danger care, evaluating the harms and benefits of inotropes, the role of IABP in community settings, and transitioning care for HF-shock patients.

  • Manage resource allocation and coordination for High-risk PCI.

  • Anticipate future directions, including the integration of novel support devices, machine learning for risk stratification, and AI in decision-making.

Target Audience

  • Translating the ideal to the real world will be intensivists (medical/cardiac), cardiologists (interventional, heart failure, critical care), cardiac surgeons, advanced practice providers (APPs), and hospital administrators representing the diversity of clinical practice settings to help you apply what you learn in community and academic hospitals, urban and rural locations, surgical and non-surgical settings, and treating patients with and without advanced heart failure. Suitable for representatives of hospitals looking to improve or formalize their shock program, including but not limited to cardiologists, intensivists, surgeons, nurses, APPs, and hospital administrators within the disciplines of critical care, cardiothoracic surgery, heart failure, interventional cardiology, and CV service line leadership.
  • Best for Interventional Cardiologists, Intensivists, Cardiothoracic Surgeons, and Advanced Practice Providers (APPs) in critical care.

Topics

  • Scientific Updates in Cardiogenic Shock and Cardiac Arrest: An Experiment With an N=1 Moving From Anecdote to Evidence (Future Trials and Therapeutic Concepts, ECLS Shock, DanGer Shock).

  • The Shock ICU Never Miss a Beat: Vasoactive Medications in Cardiogenic Shock; Debate: Dedicated Cardiac ICU vs. Mixed ICU for Cardiogenic Shock Patients; Hemodynamic Monitoring; Palliative Care.

  • Optimizing Antiplatelet Therapy in Cardiogenic Shock: Pharmacodynamics of Antiplatelet Therapies in CS; Optimal Antiplatelet Strategies in High-Risk Patients; Introductory Remarks & Cases (Part 1, Part 2); Cangrelor in AMI & CS.

  • Contemporary Management of PE Patients in Shock: ECMO and Other MCS Devices in PE; Normotensive Shock; AClytics/CB/Thrombectomy When to Do What; Who Are We Enrolling in PE Trials; The Role of Surgery in PE.

  • ECMO Workshop: What You Need to Know (Introduction, Equipment Review, Current Indications for ECMO); ECPR and ECMO (What’s New in ECMO, What’s After ECMO, Current State of ECPR, Considerations of VV ECMO).

  • CICU Shock Problem-Solving: Weaning MCS Devices in the CICU; Troubleshooting MCS Devices in the CICU; Thermodilution Principles of CI Measurement Case Presentation; Fick Principles of CI Measurement Case Presentation.

  • Cardiogenic Shock in the Cath Lab: Right Heart Hemodynamics Are They Really Necessary; MCS Escalation Identifying the Unseen Threat; Houston, We Have a Problem How Can I Voice Concerns and Make Suggestions; Case Studies and Debrief.

  • Wellness: Protecting Our Team; It Was Just Too Much!; Balancing the Workload.

  • Shock Complications: Keep Calm and Carry On Effective Use of ECPR for STEMI in an Agitated Patient; A Tale of Two Mitral Clips Mitral-TEER in Late Presenting STEMI with Acute Mitral Regurgitation and Cardiogenic Shock.

  • Combat Shock: ECMO use in Advanced Heart Failure; ECMO Hub & Spoke – Houston!.

  • The Role of EMS, Transport, and ED in the Management of Shock: The Challenges and Nuances of Transporting Patients on MCS; The ABCs of OHCA; How Level I, II, and III Shock Centers Should Work; Early Recognition of CS in EM and EMS; Difference in Profiles and Outcomes of In-House vs. Transfer Shock Patients.

  • Complex PCI – Everything is Complex in Shock!: Your Tool Box How to Make Complex PCI Simpler; Introduction Remarks & CE Information; Importance of Intravascular Imaging in Complex PCI; Case When to Use Two Stents in Coronary Bifurcation; Case Using CTO Techniques in Complex PCI; Case How to Make a Complex PCI Simpler.

  • Shock Coordinators in the ICUs: Beyond the Initial Call Tracking QI Metrics and Implementing Longitudinal Care; How to Set Up a Shock Team and Program Who’s on Your Team and How Do You Start; Shock Activation Process How to Sound the Alarm and What to Do Next; Role of Shock Coordinator Tips and Tricks to Optimize the Role.

  • Future Directions in Shock – Charting a Path Forward: Novel Support Devices and Novel Ways to Use the Ones We Already Have; Integration of EMR for Early Recognition of CS; How Artificial Intelligence Can Inform Our Decision-Making in Cardiogenic Shock; From the ER to the ICU to the OR Invasive and Noninvasive Tools for Hemodynamic Monitoring.

  • CS Care post-DanGer Shock: Not Just AMI-Shock, but HF-Shock Too; IABP An Important Tool in the Community; Harms and Benefit of Inotropes First; A Close Look at the IABP-Shock Trial.

  • Cardiogenic Shock in Women: Vascular Access Considerations in Women; SCAI/FAPCI Women in CS Consensus Document; Right Ventricular Failure in Women; Diagnosis, Recognition, and Disparities.

  • Bridging the Gap Between Shock Clinicians and the C-Suite: Case Presentation Dealing With CS Mortality & the Aftermath; Case Presentation Complexities in CS Coordination!.

  • Top Shock Cases: Spontaneous Coronary Artery Dissection A Rare Cause of an Acute Myocardial Infarction; Cardiogenic Shock from Fulminant Constrictive Pericarditis due to Campylobacter jejuni; Clipping Shock MitraClip’s Rescue from Flecainide Toxicity and Severe Mitral Regurgitation-Induced Cardiogenic Shock; Venous-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) as a Bridge to Recovery in the Treatment of Amniotic Fluid Embolism (AFE)-Induced Cardiac Arrest.

  • How and Why We Started Our Shock Programs (Invite Only): Welcome & Objectives; Challenges to Shock Care in Rural America; INOVA’s Journey in Shock An Example of a Community Hospital Accepting the Challenge.

  • The Finances of a Starting a Shock Team (Invite Only): How to Ask for Support (Insider Knowledge to Get the Support Your Program Needs); The Financial Benefits of a Shock Program.

  • Group Case Reviews (Invite Only): Case Review Table Assignments; Case 1, 2, 3, and 4.

  • SoCCC Cardiogenic Shock Team Collaborative Think Tank (Invite Only)

Reviews

There are no reviews yet.

Be the first to review “Society for Cardiovascular Angiography & Interventions SHOCK 2024”

Your email address will not be published. Required fields are marked *

twenty eight ÷ = seven
Powered by MathCaptcha